Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys
- 1 June 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 19 (6), 1042-1049
- https://doi.org/10.1128/aac.19.6.1042
Abstract
Ribavirin has been shown to have broad-spectrum antiviral. To study its tissue distribution and disappearance rate, a single dose of 10 mg/kg which contained 10 microCi of [14C]ribavirin was injected intravenously into rhesus monkeys and intramuscularly into monkeys and rats. Except for peak plasma concentrations and the initial phases of the plasma disappearance and urine excretion curves, no significant difference was observed between plasma, tissue, or urine values for intramuscularly or intravenously injected monkeys. Plasma disappearance curves were triphasic; plasma concentrations of ribavirin were similar for both monkeys and rats. Rats excreted ribavirin in the urine more rapidly and to a greater extent (82% excreted in 24 h) than did monkeys (60% excreted in 72 h). In the rat, only 3% of the injected [14C]ribavirin was detected in expired CO2. Therefore, for both species, urine was the major route for the elimination of labeled ribavirin and its metabolites from the body. In monkeys, the amount of parent drug in blood cells increased through 48 h and remained stable for 72 h, whereas in rats, ribavirin decreased at a rate similar to the plasma disappearance curve. Concentrations of ribavirin at 8 h were consistently higher in monkeys than in rats for all tissues except the brain. Thus, these differences in blood cellular components and organ content and in urine excretion suggested that there was greater tissue retention of ribavirin in monkeys than in rats.This publication has 11 references indexed in Scilit:
- Lassa Virus Infection of Rhesus Monkeys: Pathogenesis and Treatment with RibavirinThe Journal of Infectious Diseases, 1980
- EXPERIMENTAL LASSA FEVER VIRUS INFECTION SUCCESSFULLY TREATED WITH RIBAVIRINThe Lancet, 1979
- Activity of Amantadine, Rimantadine, and Ribavirin Against Swine Influenza in Mice and Squirrel MonkeysAntimicrobial Agents and Chemotherapy, 1978
- Double-Blind Evaluation of Oral Ribavirin (Virazole) in Experimental Influenza A Virus Infection in VolunteersAntimicrobial Agents and Chemotherapy, 1977
- THE RELATIONSHIP BETWEEN THE METABOLISM OF RIBAVIRIN AND ITS PROPOSED MECHANISM OF ACTIONAnnals of the New York Academy of Sciences, 1977
- THE ENZYMIC CONVERSION OF 1,2,4-TRIAZOLE-3-CARBOXAMIDE TO RIBAVIRIN-5'-PHOSPHATE AND ITS RELATIONSHIP TO THE PROPOSED MECHANISM OF ACTIONAnnals of the New York Academy of Sciences, 1977
- The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infectionThe American Journal of Clinical Nutrition, 1976
- Comparative Clinical and Laboratory Evaluation of the Prophylactic Capacity of Ribavirin, Amantadine Hydrochloride, and Placebo in Induced Human Influenza Type AThe Journal of Infectious Diseases, 1976
- Double-Blind Clinical Assessment of Ribavirin (Virazole) in the Prevention of Induced Infection with Type B Influenza VirusThe Journal of Infectious Diseases, 1976
- Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideScience, 1972